Warren B. Fingrut

Peer-Reviewed Articles

1. Smallbone, PI, Cao, K, Saliba, RM, Carmarzzi, Y, Al-Atrash, G, Alvarez, M, Rondon, G, Fingrut, WB, Aljawai, YM, Olson, AL, Alousi, AM, Chen, GL, Tanner, MR, Zou, J, Ramdial, JL, Champlin, RE, Shpall, E, Oran, B. Reduced relapse in high risk acute myeloid leukemia and myelodysplastic neoplasms with permissive HLA-DPB1 mismatches and post-transplant cyclophosphamide. Leukemia 40(5):934-945, 2026. e-Pub 2026. PMID: 41803402.
2. Mehta, RS, Aljawai, YM, Kebriaei, P, Rondon, G, Fingrut, WB, Smallbone, PI, Oran, B, Olson, AL, Champlin, RE, Shpall, E. Modeling donor age and type trade-offs for personalized selection in allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide prophylaxis. Leukemia 40(3):502-510, 2026. e-Pub 2026. PMID: 41526616.
3. Archer, A, Fingrut, WB, Alvarez, L, Yingsal, T, Chokr, N, Mayer, S, Shore, T, Gomez-Arteaga, A, Davis, E, Barker, JN. Availability of Suitable Domestic Cord Blood Grafts for Adult Allograft Recipients With Hematologic Malignancies. Transplantation and Cellular Therapy 32(1):92.e1-92.e8, 2026. e-Pub 2026. PMID: 40972960.
4. Mehta, RS, Aljawai, YM, Kebriaei, P, Fingrut, WB, Smallbone, PI, Oran, B, Olson, AL, Popat, UR, Champlin, RE, Shpall, E. Mismatched Unrelated vs Matched Related Donor Transplant With Posttransplant Cyclophosphamide Among Patients With Blood Cancers. JAMA Network Open 9(7), 2026. e-Pub 2026. PMID: 42475099.
5. Holloway, K, Muwhen, U, Fingrut, WB, Haw, J. Recruiting racialised youth to a stem cell registry in Canada. Transfusion Medicine 35(6):539-547, 2025. e-Pub 2025. PMID: 40523652.
6. Leeies, M, Collister, D, Ho, J, Hrymak, C, Christie, E, Dhanani, S, Fingrut, WB, Gahagan, J, Doucette, K, Lee, TH, Brodovsky, S, Sutha, K, Whitley, CT, Klassen, B, Rohani, K, Draenos, C, Lachowsky, N. Organ and tissue donation and transplantation in people who identify as Two-Spirit, gay, bisexual, transgender, queer, intersex, and more. Canadian Journal of Anesthesia 72(12):1751-1763, 2025. e-Pub 2025. PMID: 41430510.
7. Eng, S, Vadakkel, G, Brown, S, Murillo, S, Fingrut, WB, Devlin, SM, Cook, M, DeRespiris, L, Lin, AL, Monaco-Cermak, S, Nauffal, M, Giralt, S, Perales, MA, Barker, JN, Cho, C, Walji, M, Shah, GL. Insurance Barriers to High-Cost Anti-Infective Medications Post Allogeneic Hematopoietic Cell Transplant. Transplantation and Cellular Therapy 31(11):938.e1-938.e10, 2025. e-Pub 2025. PMID: 40645454.
8. Fingrut WB, Weyand AC. Guidelines are needed to advance health equity in hematology. Blood Adv 8(23):6127-6128, 2024. e-Pub 2024. PMID: 39312686.
9. Fingrut WB, Scaradavou A, Barker J. Accurate analysis of race/ethnicity and socioeconomic status. Blood Adv 8(20):5433-5434, 2024. e-Pub 2024. PMID: 39121365.
10. Fingrut WB, Troyer J, Russell E, Aviles MM, Della-Moretta S, Dobson D, Hasanali ZS, Hu B, Lapite A, Pillai PM, Schramm J, Villagomez L, Vo P, Wang'ondu R, Yui JC, Weyand AC. The American Society of Hematology Health Equity Compendium: examining health equity across the Blood Journals. Blood Adv 8(17):4616-4624, 2024. e-Pub 2024. PMID: 38968146.
11. Park B, Pires K, Jian CY, Sano L, Laganière N, Conway MA, Henstridge-Goudie J, Pavlenkova A, Pedram S, Okonofua S, Gélinas A, Bah B, Fattouh R, Farahbakhsh F, Fingrut WB. A library of TikToks to engage diverse populations to hematopoietic stem cell donation. Bone Marrow Transplant 59(8):1184-1189, 2024. e-Pub 2024. PMID: 38755459.
12. Khera N, Ailawadhi S, Brazauskas R, Patel J, Jacobs B, Ustun C, Ballen K, Abid MB, Diaz Perez MA, Al-Homsi AS, Hashem H, Hong S, Munker R, Schears RM, Lazarus HM, Ciurea S, Badawy SM, Savani BN, Wirk B, LeMaistre CF, Bhatt NS, Beitinjaneh A, Aljurf M, Sharma A, Cerny J, Knight JM, Kelkar AH, Yared JA, Kindwall-Keller T, Winestone LE, Steinberg A, Arnold SD, Seo S, Preussler JM, Hossain NM, Fingrut WB, Agrawal V, Hashmi S, Lehmann LE, Wood WA, Rangarajan HG, Saber W, Hahn T. Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minorities. Blood Adv 8(13):3497-3506, 2024. e-Pub 2024. PMID: 38661372.
13. Locke FL, Siddiqi T, Jacobson CA, Ghobadi A, Ahmed S, Miklos DB, Perales MA, Munoz J, Fingrut WB, Pennisi M, Gauthier J, Shadman M, Gowda L, Mirza AS, Abid MB, Hong S, Majhail NS, Kharfan-Dabaja MA, Khurana A, Badar T, Lin Y, Bennani NN, Herr MM, Hu ZH, Wang H, Baer A, Baro E, Miao H, Spooner C, Xu H, Pasquini MC. Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity. Blood 143(26):2722-2734, 2024. e-Pub 2024. PMID: 38635762.
14. Fingrut WB, Davis E, Archer A, Brown S, Devlin SM, Nhaissi M, Rapoport C, Chinapen S, Kelly A, Wells DS, Scaradavou A, Gyurkocza B, Papadopoulos EB, Politikos I, Shaffer BC, Barker J. Racial/ ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation. Blood Adv 8(11):2753-2764, 2024. e-Pub 2024. PMID: 38429097.
15. Pryce A, Van Eerden E, Cody M, Oakes J, DeSalvo A, Bannon S, Burlton C, Pawson R, Fingrut W, Barriga F, Ward J, Ingram C, Walsh M, El-Ghariani K, Ocheni S, Machin L, Allan D, Mengling T, Anthias C. Genetic Findings of Potential Donor Origin following Hematopoietic Cell Transplantation: Recommendations on Donor Disclosure and Genetic Testing from the World Marrow Donor Association. Transplant Cell Ther 30(2):143-154, 2024. e-Pub 2023. PMID: 38056629.
16. Fingrut WB, Davis E, Archer A, Brown S, Devlin S, Chinapen S, Scaradavou A, Politikos I, Blouin AG, Shaffer BC, Barker JN. Gender disparities in allograft access due to HLA-sensitization in multiparous women. Blood Adv 8(2):403-406, 2024. e-Pub 2024. PMID: 38029385.
17. Okonofua, S, Leeies, M, Yan, M, Tinga, B, Haw, J, Fingrut, WB. OA1-AM23-MN-06 | Addressing Racial Disparities in Donor Pools. Transfusion 63(S5):23A-25A, 2023. e-Pub 2023.
18. Fingrut WB, Chinapen S, Flynn J, Katrichis A, Stewart M, Davis E, Shaffer BC, Shah GL, Barker JN. Association between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate allografts in adult BMT recipients. Blood Adv 7(15):3834-3837, 2023. e-Pub 2023. PMID: 37083929.
19. Fingrut WB, Gyurkocza B, Flynn J, Davis E, Devlin S, Scaradavou A, Chinapen S, Quach S, Cho C, Giralt SA, Jakubowski AA, Lin RJ, Papadopoulos EB, Perales MA, Ponce D, Shaffer BC, Tamari R, Young JW, Politikos I, Barker JN. Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia. Blood Adv 7(15):3824-3833, 2023. e-Pub 2023. PMID: 36240477.
20. Warren B Fingrut MD, Gyurkocza B, Flynn J, Davis E, Devlin S, Scaradavou A, Chinapen S, Quach S, Cho C, Giralt SA, Jakubowski AA, Lin RJ, Papadopoulos EB, Perales M, Ponce D, Shaffer BC, Tamari R, Young JW, Politikos I, Barker JN. Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia. Blood Advances 7(15):3824-3833, 2023. e-Pub 2023.
21. Fingrut WB, Davis E, Chinapen S, Naputo K, Politikos I, Scaradavou A, Barker JN. Inaccuracies in assignment of patient race and ethnicity: implications for unrelated donor searches and health care delivery. Blood Adv 7(10):1996-1999, 2023. e-Pub 2023. PMID: 36156708.
22. Davis E, Archer A, Flynn J, Nhaissi M, Rapoport C, Suri B, Wells D, Papadopoulos E, Politikos I, Fingrut WB, Scaradavou A, Barker JN. An Optimized Search Prognosis Tool to Predict 8/8 HLA Allele-Matched Unrelated Donor Procurement. Transplant Cell Ther 29(5):312.e1-312.e5, 2023. e-Pub 2023. PMID: 36822475.
23. Alarcon Tomas, A, Fein, J, Fried, S, Flynn, J, Devlin, SM, Fingrut, WB, Anagnostou, T, Alperovich, A, Shah, NN, Fraint, E, Lin, RJ, Scordo, M, Batlevi, CL, Besser, MJ, Dahi, PB, Danylesko, I, Giralt, S, Imber, BS, Jacoby, E, Kedmi, M, Nagler, A, Lia Palomba, M, Roshal, M, Salles, G, Sauter, C, Shem-Tov, N, Shimoni, A, Yahalom, J, Yerushalmi, R, Shah, GL, Avigdor, A, Perales, MA, Shouval, R. Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma. Leukemia 37(1):154-163, 2023. e-Pub 2023. PMID: 36335261.
24. Tomas AA, Fein JA, Fried S, Flynn JR, Devlin SM, Warren B Fingrut MD, Anagnostou T, Alperovich A, Shah N, Fraint E, Lin RJ, Scordo M, Batlevi CL, Besser MJ, Dahi PB, Danylesko I, Giralt S, Imber BS, Jacoby E, Kedmi M, Nagler A, Palomba M, Roshal M, Salles GA, Sauter C, Shem-Tov N, Shimoni A, Yahalom J, Yerushalmi R, Shah GL, Avigdor A, Perales M, Shouval R. Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma. Leukemia 37(1):154-163, 2023. e-Pub 2023.
25. Ghobadi, A, Slade, M, Kantarjian, HM, Alvarenga, J, Aldoss, I, Mohammed, KA, Jabbour, EJ, Faramand, R, Shah, BD, Locke, FL, Fingrut, WB, Park, JH, Short, NJ, Gao, F, Uy, GL, Westervelt, P, DiPersio, JF, Champlin, RE, Al Malki, MM, Ravandi-Kashani, F, Kebriaei, P. The role of allogeneic transplant for adult Ph+ ALL in CR1 with complete molecular remission. Blood 140(20):2101-2112, 2022. e-Pub 2022. PMID: 35877996.
26. Nath K, Tomas AA, Flynn J, Fein JA, Alperovich A, Anagnostou T, Batlevi CL, Dahi PB, Fingrut WB, Giralt SA, Lin RJ, Palomba ML, Peled JU, Salles G, Sauter CS, Scordo M, Fraint E, Feuer E, Shah N, Slingerland JB, Devlin S, Shah GL, Gupta G, Perales MA, Shouval R. Vitamin D Insufficiency and Clinical Outcomes with Chimeric Antigen Receptor T-Cell Therapy in Large B-cell Lymphoma. Transplant Cell Ther 28(11):751.e1-751.e7, 2022. e-Pub 2022. PMID: 35944603.
27. Fingrut WB. Prioritising health equity alongside donation safety. Lancet Haematol 9(11):e802-e803, 2022. e-Pub 2022. PMID: 36156200.
28. Fingrut WB, Gyurkocza B, Davis E, Flynn J, Chinapen S, Naputo KA, Quach S, Cho C, Giralt SA, Jakubowski AA, Lin RJ, Papadopoulos E, Perales MA, Ponce DM, Shaffer BC, Sauter CS, Tamari R, Young JW, Scaradavou A, Politikos I, Barker JN. Racial disparities in access to alternative donor allografts persist in the era of "donors for all". Blood Adv 6(20):5625-5629, 2022. e-Pub 2022. PMID: 35675518.
29. Jagelaviciute G, Kum E, Li EW, Rosenfeld A, Williams K, Kandel R, DeGurse N, Park B, Okonofua S, Sano L, Gerofsky M, Sharp A, Hatkar R, Thyagu S, Fingrut WB. Why We Swab: A library of stories in stem cell donation. Transfusion 62(10):2095-2107, 2022. e-Pub 2022. PMID: 36062961.
30. Kum, E, Jagelaviciute, G, Chen, AC, Baharmand, I, Rihani, S, Rumball, G, Patel, D, Kandel, R, Okonofua, S, Li, EW, Hrycyshyn, A, Chan, SS, Kumar, SV, Williams, K, Prokosch, L, Ho, M, Park, B, Fingrut, WB. Development and evaluation of a community of practice to improve stem cell donor recruitment in Canada. Vox Sanguinis 117(4):587-596, 2022. e-Pub 2022. PMID: 34725827.
31. Fingrut WB, Chen AC, Green M, Weiss JT, Mercer D, Allan D. Development and evaluation of checklists to support the recruitment of committed hematopoietic stem cell donors. Transfusion 62(4):887-896, 2022. e-Pub 2022. PMID: 35182432.
32. Fingrut WB, DeGurse N, Hrycyshyn A, Lam B, Farrokhi K, Hatkar R, Williams K, Kumar SV, Chan SWS, Coupal D, Okonofua S, Wroot H, Pires K, Jayasinghe S, Stubbs T. Towards a more inclusive unrelated donor registry. Bone Marrow Transplant 57(4):688-690, 2022. e-Pub 2022. PMID: 35169283.
33. Warren B Fingrut MD, DeGurse N, Hrycyshyn A, Lam B, Farrokhi K, Hatkar R, Williams K, Kumar SV, Samuel Chan SW, Coupal D, Okonofua S, Wroot H, Pires K, Jayasinghe S, Stubbs T. Towards a more inclusive unrelated donor registry. Bone Marrow Transplantation 57(4):688-690, 2022. e-Pub 2022.
34. Shouval R, Alarcon Tomas A, Fein JA, Flynn JR, Markovits E, Mayer S, Olaide Afuye A, Alperovich A, Anagnostou T, Besser MJ, Batlevi CL, Dahi PB, Devlin SM, Fingrut WB, Giralt SA, Lin RJ, Markel G, Salles G, Sauter CS, Scordo M, Shah GL, Shah N, Scherz-Shouval R, van den Brink M, Perales MA, Palomba ML. Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy. J Clin Oncol 40(4):369-381, 2022. e-Pub 2022. PMID: 34860572.
35. Warren Fingrut MD, Law A, Lam W, Michelis FV, Viswabandya A, Lipton JH, Kumar R, Mattsson J, Hwan Kim DD. Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level. Annals of Hematology 100:789-798, 2021. e-Pub 2021.
36. Warren Fingrut MD, Cuperfain AB, Samuel Chan SW, Ptak E, Kahlon M, Dhaliwal J, Naidu A, Wang Y, Baribeau O, Mahmoudi T, Lee A, Suppiah R, Luo OD, Green M, Weiss JT, Mercer D, Elmoazzen H, Petraszko T, Allan D. Development and evaluation of stem cell collection procedure diagrams to support the education and recruitment of committed stem cell donors. Vox Sanguinis 116(2):239-248, 2021. e-Pub 2021.
37. Li EW, Lee A, Vaseghi‐Shanjani M, Anagnostopoulos A, Jagelaviciute G, Kum E, Petraszko T, Elmoazzen H, Allan D, Warren Fingrut MD. Multimedia resources to support the recruitment of committed hematopoietic stem cell donors: perspectives of the most‐needed donors. Transfusion 61(1):274-285, 2021. e-Pub 2021.
38. Warren Fingrut MD, Messner HA, Allan D. Targeted recruitment of optimal donors for unrelated hematopoietic cell transplantation: The Stem Cell Club process. Hematology/oncology and stem cell therapy 13(4):220-231, 2020. e-Pub 2020.
39. Warren Fingrut MD, Chen LY. Double Counting of Patients in Meta-analyses of Observational Studies. JAMA oncology 6(5):786-787, 2020. e-Pub 2020.
40. Li EW, Lee A, Vaseghi-Shanjani M, Anagnostopoulos A, Jagelaviciute G, Kum E, Petraszko T, Elmoazzen H, Allan D, Warren Fingrut MD. Development and evaluation of a whiteboard video series to support the education and recruitment of committed unrelated donors for hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation 26(11):2155-2164, 2020. e-Pub 2020.
41. W Fingrut MD, Beck LA, Lo D. Building an oncology community of practice to improve cancer care. Current Oncology 25(6):371-377, 2018. e-Pub 2018.
42. W Fingrut MD, Beck LA, Lo D. Oncology communities of practice: insights from a qualitative analysis. Current Oncology 25(6):378-383, 2018. e-Pub 2018.
43. Cheung KW, Wong IW, Warren Fingrut MD, Yu Tsai AP, Ke SR, Shojaie S, Brubacher JR, Stewart LC, Erdelyi S. Randomized controlled trial of emergency department initiated smoking cessation counselling and referral to a community counselling service. Canadian Journal of Emergency Medicine 20(4):556-564, 2018. e-Pub 2018.
44. Warren Fingrut MD, Parmar S, Cuperfain A, Rikhraj K, Charman E, Ptak E, Kahlon M, Graham A, Luong S, Wang Y, Yu J, Arora N, Suppiah R, Li EW, Lee A, Welsh C, Benzaquen M, Thatcher A, Baharmand I, Ladd A, Petraszko T, Allan D, Messner H. The Stem Cell Club: a model for unrelated stem cell donor recruitment. Transfusion 57(12):2928-2936, 2017. e-Pub 2017.
45. Warren Fingrut MD, Stewart L, Cheung KW. Choice of smoking cessation counselling via phone, text, or email in emergency department patients. Preventive medicine reports 4:597-600, 2016. e-Pub 2016.
46. Fingrut W, MD. Anatomy of a Stem Cell Drive: An Evidence-Based Approach to Stem Cell Drive Organization. UBCMJ 6(2):44-46, 2015. e-Pub 2015.
47. Fingrut W, MD. Top of the world stem cell drive: A case study in rural stem cell donor recruitment. UBC Med J 6:41-43, 2014. e-Pub 2014.

Review Articles

1. Lu, B, Okonofua, S, Farahbakhsh, F, Hatkar, R, Sano, L, Conway, MA, Kapesa, MC, Escoto, M, Leeies, M, Fingrut, WB. Addressing racial disparities in representation across blood, stem cell and organ and tissue donor pools. Vox Sanguinis 121(6):710-721, 2026. e-Pub 2026. PMID: 41748132.
2. Lu, B, Troyer, J, Krause, KJ, Lapite, A, Aviles, M, Della-Moretta, S, Dobson, DA, Farrokhi, K, Hasanali, Z, Pillai, PM, Taborda, C, Villagomez, LM, Vo, P, Wang'ondu, R, Yui, J, Weyand, A, Fingrut, WB. Understanding the impact of social determinants of health in hematology. Blood Advances 10(8):2801-2816, 2026. e-Pub 2026. PMID: 41587417.
3. Smallbone, PI, Kebriaei, P, Mendt Vilchez, MC, Shpall, E, Olson, AL, Fingrut, WB. Mesenchymal stem cells in hematology. Best Practice and Research: Clinical Haematology 38(1), 2025. e-Pub 2025. PMID: 40274341.

Other Articles

1. Fingrut, WB Leveraging TikToks in clinical practice. The Lancet Haematology 13(5):e270-e270, 2026. PMID: 42069406.
2. Fingrut, WB Mitigating Allograft Access Disparities Requires Upfront Consideration of All Alternative Donor Options. Transplantation and Cellular Therapy 32(3):228-230, 2026. PMID: 41794440.
3. Jian, Y(, Park, B, Vijenthira, S, Fingrut, WB Perspectives of potential haematopoietic stem-cell donors on education TikToks. The Lancet Haematology 12(11):e859-e861, 2025. PMID: 41193115.
4. Schneidman, J, So, V, Hatkar, R, Sano, L, Koette, J, Ivaturi, S, Fingrut, WB Building health advocacy campaigns to engage sexual and gender minority populations with health care. The Lancet Haematology 12(1):e11-e13, 2025. PMID: 39756842.

Abstracts

1. Popat UR, Alousi AM, Bassett RL, Alatrash G, Aljawai YM, Bashir Q, Chen GL, Fingrut WB, Hosing CM, Im JS, Kebriaei P, Khouri IF, Marin D, Mehta RS, Nieto Y, Olson AL, Oran B, Qazilbash MH, Ramdial JL, Saini NY, Shigle TL, Smallbone P, Srour SA, Champlin RE, Shpall EJ. Jak Inhibitor Itacitinib with Ptcy and Tacrolimus to Prevent Gvhd in a Myeloablative Fractionated Busulfan Regimen: A Phase 2 Trial. ASTCT 2025, 2025. e-Pub 2025.
2. Aljawai YM, Smallbone P, Alousi AM, Bashir Q, Chen GL, Fingrut WB, Hosing CM, Kebriaei P, Marin D, Oran B, Popat UR, Qazilbash MH, Ramdial JL, Rezvani K, Champlin RE, Shpall Mehta EJRS. Impact of Donor Age and Donor-Recipient Sex Mismatch on Hematopoietic Cell Transplantation Outcomes. ASTCT 2025, 2025. e-Pub 2025.
3. Cervoni-Curet FN, Milton DR, Garcia R, Hunter L, Ledesma C, Martinez CS, Rondon G, Carmazzi Y, Cao K, Al-Atrash G, Aljawai YM, Alousi AM, Bashir Q, Chen GL, Hosing CM, Im JS, Kebriaei P, Khouri IF, Marin D, Mehta RS, Nieto Y, Olson AL, Oran B, Popat UR, Qazilbash MH, Ramdial JL, Smallbone P, Saini NY, Srour SA, Champlin RE, Flowers C, Shpall EJ, Fingrut WB. Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide (PTCy)-Based Graft-Versus-Host Disease Prophylaxis. ASTCT 2025, 2025. e-Pub 2025.
4. Popat UR, Bassett RL, Alousi AM, Alatrash G, Aljawai YM, Bashir Q, Chen GL, Fingrut WB, Gulbis AM, Hosing CM, Im JS, Kebriaei P, Marin D, Mehta RS, Nieto Y, Olson AL, Oran B, Qazilbash MH, Ramdial JL, Saini NY, Smallbone P, Srour SA, Valdez BC, Champlin RE, Andersson BS, Shpall EJ. Myeloablative Fractionated Busulfan, Fludarabine, Cladribine, Thiotepa and Venetoclax (Cladillac) Conditioning Regimen for Allogeneic Stem Cell Transplantation in Very High-Risk AML/MDS: A Phase 2 Trial. ASTCT 2025, 2025. e-Pub 2025.
5. Hosing CM, Saliba RM, Alousi AM, Alatrash G, Aljawai YM, Bashir Q, Chen GL, Fingrut WB, Im JS, Kebriaei P, Marin D, Nieto Y, Olson AL, Oran B, Qazilbash MH, Ramdial JL, Saini NY, Smallbone P, Srour SA, Bazinet A, Garcia-Manero G, Champlin RE, Andersson BS, Shpall EJ, Popat UR. Allogeneic Stem Cell Transplant with Myeloablative Fractionated Busulfan, Fludarabine and Thiotepa Conditioning Regimen in Older Patients with High Risk MDS. ASTCT 2025, 2025. e-Pub 2025.
6. Smallbone P, Cao K, Saliba RM, Alvarez M, Fingrut WB, Aljawai Y, Olson AL, Alousi AM, Chen G, Ramdial J, Champlin RE, Shpall EJ, Oran B. HLA-DPB1 Mismatches and the Impact on Unrelated Donor Transplant Outcomes with the Use of Post-Transplant Cyclophosphamide. ASH 2024, 2024. e-Pub 2024.
7. Troyer J, Lu B, Krause K, Aviles M, Della-Moretta S, Dobson D, Farrokhi K, Hasanali ZS, Lapite A, Pillai P, Taborda C, Villagomez L, Vo PT, Wang’ondu R, Yui JC, Weyand AC, Fingrut WB. Analysis of the Hematology Health Equity Literature: Trends By Topic and Disparity, across Journals, and over Time. ASH 2024, 2024. e-Pub 2024.
8. Popat U, MD, Bassett RL, MS, Alousi AM, M, Alatrash G, PhD, DO, Aljawai YM, MD, MS, Bashir Q, MD, Chen G, MD, Fingrut WB, MD, Hosing C, MD, Im JS, MD, PhD, Kebriaei P, MD, Marin D, MD, Nieto Y, MD, PhD, Olson AL, MD, Oran B, MD, MS, Qazilbash MH, MD, Ramdial J, MD, Saini NY, MD, Smallbone P, MD, Srour SA, MD, Valdez BC, PhD, Champlin RE, MD, Andersson BS, MD, PhD, Shpall EJ, MD. Myeloablative Fractionated Busulfan, Fludarabine, Cladribine, Thiotepa and Venetoclax (Cladillac) Conditioning Regimen for Very High-Risk AML/MDS: A Phase 2 Trial. ASH 2024, 2024. e-Pub 2024.
9. Smith NG, Fingrut WB, Waters N, Piasevoli K, Fei T, Slingerland J, Peled JU, Ponce DM. Disparities in Microbiota Diversity Impacting Non-European Recipients of 8/8 HLA-Matched Unrelated Donor Transplantation. ASH 2024, 2024. e-Pub 2024.
10. Cervoni Curet FN, Bassett RL, Pasvolsky O, Deen AF, Tanner MR, Bashir Q, Srour SA, Saini NY, Ramdial J, Nieto Y, Lee HC, Patel KK, Kebriaei P, Fingrut WB, Smallbone P, Becnel MR, Gaballa MR, Thomas SK, Ye J, Orlowski RZ, Champlin RE, Shpall EJ, Qazilbash MH. Impact of Ethnicity on Long Term Outcomes of High-Dose Chemotherapy and Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma. ASH 2024, 2024. e-Pub 2024.
11. Fingrut WB, Codrington K, Hunter L, Garcia R, Martinez C, Rondon G, Milton DR, Flowers CR, Shpall EJ. Prospective Observational Cohort Study to Collect Granular Social Determinants of Health Data for Transplant and Cellular Therapy Candidates and Recipients. ASH 2024, 2024. e-Pub 2024.
12. Politikos I, Fingrut WB, Brown S, Chinapen S, Quach S, Dahi PB, Gyurkocza B, Jakubowski AA, Papadopoulos EB, Ponce DM, Tamari R, Perales M, Scaradavou A, Barker JN. High Progression-Free Survival with Low Relapse Rates after Double-Unit Cord Blood Transplantation in Patients with High-Risk AML. Blood 142(Supplement 1), 2023. e-Pub 2023.
13. Fingrut WB, Davis E, Archer A, Brown S, Devlin SM, Chinapen S, Scaradavou A, Politikos I, Blouin A, Shaffer BC, Barker JN. Gender Disparities in Allograft Access Due to HLA-Sensitization in Multiparous Women: Implications for Evaluation of Female Patients for Alternative Donor Transplantation. Blood 142(Supplement 1), 2023. e-Pub 2023.
14. Fingrut WB, Davis E, Archer A, Brown S, Devlin SM, Nhaissi M, Rapoport C, Chinapen S, Kelly A, Wells D, Scaradavou A, Gyurkocza B, Papadopoulos EB, Politikos I, Shaffer BC, Barker JN. Analysis of 3,843 Unrelated Donors (URD) for 455 Allograft Candidates Reveals Low URD Availability with Marked Racial/ Ethnic Disparities: Major Implications for Transplant Center & Registry Operations. Blood 142(Supplement 1), 2023. e-Pub 2023.
15. Okonofua S, Rosenfeld A, Segall R, Leeies M, Yan M, Haw J, Fingrut WB. Advancing a More Inclusive Blood and Transplant System for Marginalized Groups”: Development and Evaluation of a Transfusion Medicine Health Equity and Advocacy Curriculum. Blood 142(Supplement 1), 2023. e-Pub 2023.

Book Chapters

1. Fingrut W, Pastores SM, Rosenzweig MA, Jakubowski AA. Hematopoietic Stem Cell Transplantation and Graft-Versus-Host Disease. In: Schmidt and Wood’s Principles of Critical Care, 5th Edition Eds. Gregory A. Schmidt. McGraw Hill, 2023.

Letters to the Editor

1. Mehta, RS, Aljawai, YM, Fingrut, WB, Smallbone, PI, Rondon, G, Olson, AL, Oran, B, Kebriaei, P, Champlin, RE, Shpall, E. Uncoupling toxicity from efficacy in donor selection for allogeneic hematopoietic cell transplantation. Journal of Hematology and Oncology 19, 2026.
2. Fingrut, WB, Scaradavou, A, Barker, JN. Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation. Journal of Clinical Oncology 43: 475-476, 2025.